Zepbound, which activates both GLP-1 and GIP receptors, may offer enhanced appetite control and greater weight loss benefits for some individuals
But here is the critical detail
It is a problem that were seeing in [these] communities. Serrano said underserved populations are also vulnerable to the marketing of compounded and counterfeit GLP-1s in multiple forms of media
Funding This work was in part supported by Fondi di Ateneo from the Universit della Calabria (to CI, MS, MG, and LP) and in part by PON (Programma Operativo Nazionale) Project No
In fact, 83.5% of the patients who developed complications at the end of the study already had DR at baseline, and the level was not described in the paper
This makes the disease more difficult to treat (23)